Cabio Bioengineering (Wuhan) Overview

  • Founded
  • 2004
Founded
  • Status
  • Public
  • Employees
  • 374
Employees
  • Stock Symbol
  • 688089
Stock Symbol
  • Share Price
  • $8.30
  • (As of Monday Closing)

Cabio Bioengineering (Wuhan) General Information

Description

Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.

Contact Information

Website
www.cabio.cn
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Food Products
Other Industries
Biotechnology
Stock Exchange
SHG
Primary Office
  • No. 999, Gaoxin Avenue, East Lake New Technology
  • Development Zone
  • Wuhan, 430073
  • China
+86 027 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cabio Bioengineering (Wuhan) Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.30 $8.38 $5.30 - $10.19 $1.01B 120M 1.58M $0.16

Cabio Bioengineering (Wuhan) Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 727,141 605,816 618,417
Revenue 50,619 46,820 45,089 43,249
EBITDA 26,349 26,032 24,278 21,339
Net Income 19,146 18,902 17,103 14,661
Total Assets 216,934 211,657 185,489 84,488
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cabio Bioengineering (Wuhan) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cabio Bioengineering (Wuhan)‘s full profile, request access.

Request a free trial

Cabio Bioengineering (Wuhan) Executive Team (1)

Name Title Board Seat Contact Info
Dewei Yi Founder, Chairman, President & General Manager
To view Cabio Bioengineering (Wuhan)’s complete executive team members history, request access »

Cabio Bioengineering (Wuhan) Board Members (1)

Name Representing Role Since
00000 00 Cabio Bioengineering (Wuhan) Founder, Chairman, President & General Manager 000 0000
To view Cabio Bioengineering (Wuhan)’s complete board members history, request access »

Cabio Bioengineering (Wuhan) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cabio Bioengineering (Wuhan) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cabio Bioengineering (Wuhan)‘s full profile, request access.

Request a free trial